IMA
ImageneBio IncNASDAQHealthcare$4.97-1.58%ClosedMarket Cap: $55.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.42
P/S
0.00
EV/EBITDA
-0.61
DCF Value
$4.98
FCF Yield
-86.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-34.0%
ROA
-28.2%
ROIC
-37.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-8.5M | $-6.9M | $-0.62 | — |
| FY 2025 | $800.0K | -29.1% | $-48.5M | $-45.3M | $-10.76 | — |
| Q3 2025 | $0.00 | NaN% | $-26.6M | $-24.8M | $-3.01 | — |
| Q2 2025 | $0.00 | -Infinity% | $-8.8M | $-2.8M | $-0.06 | — |
| Q1 2025 | $0.00 | -Infinity% | $-10.8M | $-8.6M | $-0.18 | — |
| Q4 2024 | $0.00 | -Infinity% | $-12.5M | $-9.1M | $-0.19 | — |
| FY 2024 | $3.5M | 100.0% | $-37.0M | $-36.6M | $-1.02 | — |
| Q3 2024 | $0.00 | -Infinity% | $-12.4M | $-10.2M | $-0.21 | — |
| Q2 2024 | $0.00 | -Infinity% | $-15.8M | $-13.7M | $-0.28 | — |
| Q1 2024 | $0.00 | -Infinity% | $-18.2M | $-16.1M | $-0.33 | — |
| Q4 2023 | $659.0K | 53.7% | $-21.9M | $-19.5M | $-0.41 | — |
| FY 2023 | $9.2M | 88.9% | $-75.4M | $-68.2M | $-1.63 | — |